Andrew J. Fromkin

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Immunovant Inc., 3 years.

Immunovant Inc. Director
3 years · Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 28, 2026 Immunovant Inc. Option exercise +31,668 $4.99 $158,023
May 28, 2026 Immunovant Inc. Option exercise +71,492 $7.94 $567,646
May 28, 2026 Immunovant Inc. Option exercise +77,181 $8.43 $650,636
May 28, 2026 Immunovant Inc. Option exercise +16,260 $14.70 $239,022
May 28, 2026 Immunovant Inc. Open-market sale −11,483 $32.64 $374,805
May 28, 2026 Immunovant Inc. Open-market sale −210,468 $33.56 $7,063,306
Apr 7, 2026 Immunovant Inc. Grant or award +13,880 — —
Dec 1, 2025 Immunovant Inc. Open-market sale −19,351 $23.14 $447,782
Dec 1, 2025 Immunovant Inc. Open-market sale −2,898 $23.95 $69,407
Apr 1, 2025 Immunovant Inc. Grant or award +16,188 — —
Mar 7, 2025 Immunovant Inc. Open-market sale −6,616 $19.52 $129,144
Mar 7, 2025 Immunovant Inc. Open-market sale −1,384 $19.96 $27,625
Apr 2, 2024 Immunovant Inc. Grant or award +11,255 — —
Dec 1, 2023 Immunovant Inc. Open-market sale −3,941 $38.78 $152,832
Dec 1, 2023 Immunovant Inc. Open-market sale −3,636 $39.81 $144,749

Questions about Andrew J. Fromkin

What boards is Andrew J. Fromkin on?

Andrew J. Fromkin sits on the board of Immunovant Inc.

How long has Andrew J. Fromkin served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.